Find and Pitch Jounalists, Get Your Story Covered

Tags: Tessellate BIO Dr Lara Boyd CBO Department for Science Innovation and Technology UK government

	Profile	Recent Articles on Subject
1	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	As financial headwinds pick up, pharmas are aiming to squeeze more ROI from their R&D - 3 months ago The big rebrand: Why these 4 biopharmas changed their name this year - 5 months ago The Dodgers’ World Series run brought attention to a rare disease. Annexon is stepping up to the plate. - 5 months ago An Alzheimer’s drugmaker is accused of data ‘manipulation.’ Should its trials be stopped? - 7 months ago Five years after closing the Shire deal, Takeda is ready to harvest from its latest reinvention - over 1 year ago
2	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	Eli Lilly seeks to join lawsuit on compounded drugs - 4 months ago Sanofi pours $1 billion into China for insulin plant - 5 months ago A win for Apellis, a setback for Astellas - 5 months ago Novartis is building a new radioligand plant in China - over 1 year ago
3	Nick Paul Taylor MedTech Dive Top 5 Mario Kart Player. Gaming	Labcorp closes takeover of Ballad Health outreach laboratory services - 4 months ago Quest to buy Lifelabs for $985M - 10 months ago Labcorp inks $237.5M buyout of Opko’s reproductive, women’s health testing assets - about 1 year ago
4	Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile educationpolitics	How Astellas juggles the moving parts of cancer precision medicine development - 5 months ago A new biotech tackling IBD joins a race against Lilly and Gilead for a promising pill - 9 months ago Big Pharma players Amgen, Roche and Pfizer seek to follow in Novo and Lilly’s weight loss footsteps - about 1 year ago
5	Rebecca Pifer Healthcare Dive Reporter @healthcaredive. New York City, United States insurancedigital health	Sanofi joins J&J, Eli Lilly in proposing 340B rebate model - 5 months ago
6	Beth Mole Ars Technica Senior Health Reporter @ArsTechnica. microbiologyinfectious diseasespublic health	Drugmaker shut down after black schmutz found in injectable weight-loss drug - 6 months ago
7	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Pfizer’s quest for market share in the ‘high stakes battleground’ of oral GLP-1s - 6 months ago FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage - 6 months ago In a Duchenne market beset by problems, Capricor data marks a bright spot - 9 months ago
8	Adam Spatacco Motley Fool Community for top investors. Investingcommunity	This is Huge News For Eli Lilly Investors - 6 months ago Did Eli Lilly Just Get a Leg Up on Novo Nordisk? - 10 months ago This Is Massive News for Eli Lilly Investors - 10 months ago Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making - 12 months ago Prediction: Eli Lilly and Novo Nordisk Stock Could Just be Getting Started. Here's Why - about 1 year ago
9	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Eli Lilly Plans $4.5B Medicine Foundry to Foster Innovations in Drug Manufacturing - 7 months ago Amylyx Withdraws ALS Drug From Market; Restructuring Will Slash 70% of Staff - about 1 year ago
10	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	Direct-to-Consumer Drugs: Big Pharma's Digital Health Play - 7 months ago

Journalists covering Dr. Reddy's Laboratories